New York State Common Retirement Fund
BEAM icon

New York State Common Retirement Fund’s Beam Therapeutics BEAM Stock Holding History

New York State Common Retirement Fund’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
35,502
+4,873
+16% +$147K ﹤0.01% 1656
2026
Q1 		$730K Hold
30,629
– – ﹤0.01% 1775
2025
Q4 		$849K Hold
30,629
– – ﹤0.01% 1769
2025
Q3 		$743K Hold
30,629
– – ﹤0.01% 1794
2025
Q2 		$521K Buy
30,629
+4,600
+18% +$80.1K ﹤0.01% 1892
2025
Q1 		$508K Buy
26,029
+3,300
+15% +$86.4K ﹤0.01% 1879
2024
Q4 		$564K Hold
22,729
– – ﹤0.01% 1902
2024
Q3 		$557K Sell
22,729
-8,800
-28% -$227K ﹤0.01% 1903
2024
Q2 		$739K Buy
31,529
+533
+2% +$13.1K ﹤0.01% 1887
2024
Q1 		$1.02M Buy
30,996
+2,370
+8% +$73.8K ﹤0.01% 1765
2023
Q4 		$779K Sell
28,626
-1,008
-3% -$25K ﹤0.01% 1901
2023
Q3 		$713K Buy
29,634
+263
+0.9% +$7.05K ﹤0.01% 1913
2023
Q2 		$938K Sell
29,371
-15,721
-35% -$510K ﹤0.01% 1803
2023
Q1 		$1.38M Sell
45,092
-10,315
-19% -$407K ﹤0.01% 1725
2022
Q4 		$2.17M Buy
55,407
+3,709
+7% +$166K ﹤0.01% 1592
2022
Q3 		$2.46M Buy
51,698
+1,550
+3% +$88.4K ﹤0.01% 1504
2022
Q2 		$1.94M Buy
50,148
+6,459
+15% +$257K ﹤0.01% 1680
2022
Q1 		$2.5M Buy
43,689
+3,650
+9% +$239K ﹤0.01% 1627
2021
Q4 		$3.19M Sell
40,039
-1,583
-4% -$136K ﹤0.01% 1521
2021
Q3 		$3.62M Sell
41,622
-6,606
-14% -$664K ﹤0.01% 1449
2021
Q2 		$6.21M Buy
48,228
+2,578
+6% +$205K 0.01% 1234
2021
Q1 		$3.65M Hold
45,650
– – ﹤0.01% 1426
2020
Q4 		$3.73M Buy
45,650
+12,250
+37% +$602K ﹤0.01% 1366
2020
Q3 		$822K Buy
33,400
+15,700
+89% +$389K ﹤0.01% 2005
2020
Q2 		$496K Buy
17,700
+11,100
+168% +$239K ﹤0.01% 2211
2020
Q1 		$119K Buy
+6,600
New +$143K ﹤0.01% 2693

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

New York State Common Retirement Fund's BEAM Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Beam Therapeutics (BEAM) stake by 16% in Q2 2026, buying an estimated $147K and bringing the position to 35,502 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1656.

New York State Common Retirement Fund first reported a position in BEAM in Q1 2020 and has held it in 26 quarters since. The position peaked at $6.21M in Q2 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • New York State Common Retirement Fund held 35,502 shares of Beam Therapeutics worth $1.22M as of Q2 2026.
  • New York State Common Retirement Fund bought 4,873 Beam Therapeutics shares in Q2 2026, an estimated $147K.
  • Beam Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1656 holding.
  • New York State Common Retirement Fund first reported a position in Beam Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • New York State Common Retirement Fund's Beam Therapeutics position peaked at $6.21M in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.